Ionis Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $9 million in its fourth quarter.

On a per-share basis, the Carlsbad, California-based company said it had a loss of 6 cents.

The results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.

The drug discovery and development company posted revenue of $325 million in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $183.6 million.

For the year, the company reported a loss of $366 million, or $2.56 per share. Revenue was reported as $788 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS

Advertisement

Recommended Stories